A Study to Test How Well Empagliflozin Works in Japanese People With Type 2 Diabetes Who Are Older Than 65 Years

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This study is to assess the efficacy of empagliflozin 10 mg after 52 weeks compared to placebo in elderly patients with Type 2 diabetes mellitus (T2DM) and to explore if empagliflozin has any impact on patient physical condition compared to placebo in elderly patients with T2DM.
Epistemonikos ID: c4dcc9911e46ea401de7724d127c51d942dc4d76
First added on: May 07, 2024